Insider Stock Trading History of Mcmanus John L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mcmanus John L since year 2005. The trader's CIK number is 1193923. At the time of this reporting, Mcmanus John L is the President and CEO of Aeolus Pharmaceuticals, Inc. . (stock ticker symbol AOLS). See this page for all insider trading activities at Aeolus Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Mcmanus John L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-03-06 AOLS Aeolus Pharmaceuticals, Inc. Buy 10,000 .35 3,500
2011-05-24 AOLS Aeolus Pharmaceuticals, Inc. Buy 10,300 .46 4,738
2011-05-18 AOLS Aeolus Pharmaceuticals, Inc. Buy 20,000 .43 8,600
2011-03-15 AOLS Aeolus Pharmaceuticals, Inc. Buy 10,000 .74 7,410
2010-04-15 AOLS Aeolus Pharmaceuticals, Inc. Buy 10,000 .40 4,000
2008-10-01 AOLS Aeolus Pharmaceuticals, Inc. Buy 18,000 .39 7,020
2008-10-01 AOLS Aeolus Pharmaceuticals, Inc. Sale 18,000 .44 7,830
2007-07-30 AOLS Aeolus Pharmaceuticals, Inc. Buy 5,000 .55 2,750
2006-07-19 AOLS Aeolus Pharmaceuticals, Inc. Buy 1,000 .75 750
2006-03-21 AOLS Aeolus Pharmaceuticals, Inc. Buy 5,000 .84 4,175
2005-12-30 AOLS Aeolus Pharmaceuticals, Inc. Buy 1,000 .95 950
2005-09-22 AOLS Aeolus Pharmaceuticals, Inc. Buy 2,500 1.08 2,712
2005-08-23 AOLS Aeolus Pharmaceuticals, Inc. Buy 500 .91 455
2005-08-10 AOLS Aeolus Pharmaceuticals, Inc. Buy 4,000 .97 3,880
2005-07-21 AOLS Aeolus Pharmaceuticals, Inc. Buy 1,000 .97 970
2005-07-08 AOLS Aeolus Pharmaceuticals, Inc. Buy 10,000 .95 9,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcmanus John L (President and CEO of Aeolus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.